Dynamic expression of epoxyeicosatrienoic acid synthesizing and metabolizing enzymes in the primate corpus luteum

Molecular Human Reproduction

Volumn 13, Issue 8, 2007, Pages 541-548

  Irusta, G ^a,c   Murphy, M J ^a   Perez, W D ^a   Hennebold, J D ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

Corpus luteum; Epoxyeicosatrienoic acid; Epoxygenase; Ovary; Soluble epoxide hydrolase

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; GESTAGEN; ICOSATRIENOIC ACID; LUTEINIZING HORMONE; MESSENGER RNA; STEROID HORMONE;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS LUTEUM; ENDOTHELIUM CELL; ENZYME LOCALIZATION; FEMALE; INFLAMMATION; ION TRANSPORT; LUTEAL CELL; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RHESUS MONKEY; STEROIDOGENESIS; STROMA CELL; VASCULAR ENDOTHELIUM;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; CORPUS LUTEUM; CYTOCHROME P-450 ENZYME SYSTEM; EPOXIDE HYDROLASES; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; MACACA MULATTA; OXIDOREDUCTASES; RNA, MESSENGER;

MACACA MULATTA; PRIMATES;

EID: 34547804798     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gam044     Document Type: Article

References (51)

1. Ayajiki K, Fujioka H, Toda N, Okada S, Minamiyama Y, Imaoka S, Funae Y, Watanabe S, Nakamura A, Okamura T. Mediation of arachidonic acid metabolite(s) produced by endothelial cytochrome P-450 3A4 in monkey arterial relaxation. Hypertens Res 2003;26:237-243.
2. Beetham JK, Grant D, Arand M, Garbarino J, Kiyosue T, Pinot F, Oesch F, Belknap WR, Shinozaki K, Hammock BD. Gene evolution of epoxide hydrolases and recommended nomenclature. DNA Cell Biol 1995;14 61-71.
3. Borhan B, Mebrahtu T, Nazarian S, Kurth MJ, Hammock BD. Improved radiolabeled substrates for soluble epoxide hydrolase. Anal Biochem 1995;231:188-200.
4. Bylund J, Ericsson J, Oliw EH. Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS. Anal Biochem 1998;265:55-68.
5. Campbell WB, Falck JR, Gauthier K. Role of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factor: In bovine coronary arteries. Med Sci Monit 2001;7:578-584.
6. Chacos N, Capdevila J, Falck JR, Manna S, Martin-Wixtrom C, Gill SS, Hammock BD, Estabrook RW. The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. Arch Biochem Biophys 1983;223:639-648.
7. Chen J-K, Wang D-W, Falck JR, Capdevila JH, Harris RC. Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second, messenger in response to epidermal growth factor. J Biol Chem 1999;274: 4764-4769.
8. Denlinger CL, Vesell ES. Hormonal regulation of the developmental pattern of epoxide hydrolases. Studies in rat liver. Biochem Pharmacol 1989;38: 603-610.
9. Duffy DM, Chaffin CL, Stouffer RL. Expression of estrogen receptor alpha and beta in the rhesus monkey corpus luteum during the menstrual cycle: regulation by luteinizing hormone and progesterone. Endocrinology 2000;141:1711-1717.
10. Duffy DM, Stewart DR, Stouffer RL. Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys. J Clin Endocrinol Metab 1999;84:342-349.
11. Enayetallah AE, French RA, Thibodeau MS, Grant DF. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 2004;52:447-454.
12. Fang X, Moore SA, Stoll LL, Rich G, Kaduce TL, Weintraub NL, Spector AA. 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells. Am J Physiol 1998;275 H2113-H2121.
13. Fisslthaler B, Hinsch N, Chataigneau T, Popp R, Kiss L, Busse R, Fleming I. Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension 2000;36:270-275.
14. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999;401:493-497.
15. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol 1994;481 407-414.
16. Hennebold JD, Mah K, Perez W, Vance JE, Stouffer RL, Morisseau C, Hammock BD, Adashi EY. Identification and characterization of an ovary-selective isoform of epoxide hydrolase. Biol Reprod 2005; 72:968-975.
17. Ikeya K, Jaiswal AK, Owens RA, Jones JE, Nebert DW, Kimura S. Human CYP1A2: Sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression. Mol Endocrinol 1989;3:1399-1408.
18. Imig JD, Zhao X, Zaharis CZ, Olearczyk JJ, Pollock DM, Newman JW, Kim IH, Watanabe T, Hammock BD. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension 2005;46:975-981.
19. Inoue N, Fujiwara K, Iwata T, Imai K, Aimoto T. Involvement of pituitary hormone in the sex-related regulation of hepatic epoxide hydrolase activity in mice. Biol Pharm Bull 1995;18:536-539.
20. Inoue N, Yamada K, Imai K, Aimoto T. Sex hormone-related control of hepatic epoxide hydrolase activities in mice. Biol Pharm Bull 1993;16:1004-1007.
21. Klose TS, Blaisdell JA, Goldstein JA. Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J Biochem Mol Toxicol 1999;13:289-295.
22. Kroetz DL, Zeldin DC. Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol 2002;13:273-283.
23. Larsen BT, Gutterman DD, Hatoum OA. Emerging role of epoxyeicosatrienoic acids in coronary vascular function. Eur J Clin Invest 2006;36 293-300.
24. Newman JW, Morisseau C, Hammock BD. Epoxide hydrolases: Their roles and interactions with lipid metabolism. Prog Lipid Res 2005;44 1-51.
25. Newman JW, Stok JE, Vidal JD, Corbin CJ, Huang Q, Hammock BD, Conley AJ. Cytochrome p450-dependent lipid metabolism in preovulatory follicles. Endocrinology 2004;145:5097-5105.
26. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999;285:1276-1279.
27. Node K, Ruan XL, Dai J, Yang SX, Graham L, Zeldin DC, Liao JK. Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem 2001;276:15983-15989.
28. Peri KG, Almazan G, Varma DR, Chemtob S. A role for protein kinase C alpha in stimulation of prostaglandin G/H synthase-2 transcription by 14,15-epoxyeicosatrienoic acid. Biochem Biophys Res Commun 1998; 244:96-101.
29. Peri KG, Varma DR, Chemtob S. Stimulation of prostaglandin G/H synthase-2 expression by arachidonic acid monoxygenase product, 14,15-epoxyeicosatrienoic acid. FEBS Lett 1997;416:269-272.
30. Pinot F, Grant DF, Spearow JL, Parker AG, Hammock BD. Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice. Biochem Pharmacol 1995;50:501-508.
31. Pozzi A, Macias-Perez I, Abair T, Wei S, Su Y, Zent R, Falck JR, Capdevila JH. Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids. J Biol Chem 2005;280: 27138-271446.
32. Pratt PF, Li P, Hillard CJ, Kurian J, Campbell WB. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. Am J Physiol Heart Circ Physiol 2001;280 H1113-H1121.
33. Rifkind AB, Lee C, Chang TK, Waxman DJ. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: Regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys 1995;320:380-389.
34. Schuetz JD, Beach DL, Guzelian PS. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 1994;4:11-20.
35. Spector AA, Norris AW. Action of epoxyeicosatrienoic acids (EETs) on cellular function. Am J Physiol Cell Physiol 2006;
36. Stouffer RL. The functions and regulation of cell populations comprising the corpus luteum during the ovarian cycle. In: Leung PCK, Adashi EY (ed). The Ovary.: Elsevier Academic PressSan Diego, 2004,169-184.
37. Van Voorhis BJ, Dunn MS, Falck JR, Bhatt RK, VanRollins M, Snyder GD. Metabolism of arachidonic acid to epoxyeicosatrienoic acids by human granulosa cells may mediate steroidogenesis. J Clin Endocrinol Metab 1993;76:1555-1559.
38. Wang X, Shen CL, Dyson MT, Yin X, Schiffer RB, Grammas P, Stocco DM. The involvement of epoxygenase metabolites of arachidonic acid in cAMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression. J Endocrinol 2006;190:871-878.
39. Wang Y, Wei X, Xiao X, Hui R, Card JW, Carey MA, Wang DW, Zeldin DC. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. J Pharmacol Exp Ther 2005;314:522-532.
40. Wolf DP, Thomson JA, Zelinski-Wooten MB, Stouffer RL. In vitro fertilization-embryo transfer in nonhuman primates: The technique and its applications. Mol Reprod Dev 1990;27:261-280.
41. Wrighton SA, Stevens JC, Becker GW, VandenBranden M. Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4′-hydroxylation. Arch Biochem Biophys 1993;306:240-245.
42. Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 1996;271 3460-3468.
43. Young KA, Hennebold JD, Stouffer RL. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. Mol Hum Reprod 2002;8:833-840.
44. Young KA, Stouffer RL. Gonadotropin and steroid regulation of matrix metalloproteinases and their endogenous tissue inhibitors in the developed corpus luteum of the rhesus monkey during the menstrual cycle. Biol Reprod 2004;70:244-252.
45. Young KA, Tumlinson B, Stouffer RL. ADAMTS-1/METH-1 and TIMP-3 expression in the primate corpus luteum: Divergent patterns and stage-dependent regulation during the natural menstrual cycle. Mol Hum Reprod 2004;10:559-565.
46. Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW, Parker C, Graham L, Engler MM, Hammock BD et al. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 2000;87:992-998.
47. Zeldin DC, Moomaw CR, Jesse N, Tomer KB, Beetham J, Hammock BD, Wu S. Biochemical characterization of the human liver 'P450 arachidonic acid epoxygenase pathway. Arch Biochem Biophys 1996;330:87-96.
48. Zhang B, Cao H, Rao GN. Fibroblast growth factor-2 is a downstream mediator of phosphatidylinositol 3-kinase-Akt signaling in 14,15-epoxyeicosatrienoic acid-induced angiogenesis. J Biol Chem 2006;281:905-914.
49. Zhao X, Imig JD. Kidney CYP450 enzymes: Biological actions beyond drug metabolism. Curr Drug Metab 2003;4:73-84.
50. Zosmer A, Elder MG, Sullivan MH. Production of intracellular arachidonic acid metabolites by human granulosa. cells. Prostaglandins Leukot Essent Fatty Acids 1990;41:265-267.
51. Zosmer A, Elder MG, Sullivan MH. The production of progesterone and 5,6-epoxyeicosatrienoic acid by human granulosa cells. J Steroid Biochem Mol Biol 2002;81:369-376.